Understanding Antibody Dilution Ratios
Dilution ratios like 2:10 and 1:40 represent how much patient serum is mixed with diluent—2:10 means 2 parts serum to 10 parts total volume (equivalent to 1:5), while 1:40 means 1 part serum to 40 parts total volume, making 1:40 a much more dilute solution that requires higher antibody concentrations to produce a positive result.
How Dilution Ratios Work
The notation uses the format of serum:total volume or serum:diluent:
- 2:10 dilution = 2 parts serum + 8 parts diluent = 10 parts total (this is actually a 1:5 dilution when expressed as serum:total)
- 1:40 dilution = 1 part serum + 39 parts diluent = 40 parts total
Higher dilution numbers (like 1:160) mean more dilute samples, requiring stronger antibody presence to remain positive.
Clinical Significance in ANA Testing
The choice of screening dilution profoundly impacts test interpretation:
Low Dilutions (1:40)
- 31.7% of healthy individuals test positive at 1:40 dilution 1, 2
- High sensitivity but poor specificity
- Commonly used for pediatric screening (<16 years) 1
- Results in numerous false positives and potential misdiagnosis 3
Intermediate Dilutions (1:80)
- 13.3% of healthy individuals test positive at 1:80 1, 2
- Most common screening dilution worldwide (used by 60% of laboratories) 4
- Optimal balance of sensitivity and specificity for adult CTD diagnosis 3
- Reduces false positives while maintaining 96.4% sensitivity for ANA-related conditions 3
Higher Dilutions (1:160)
- Only 5.0% of healthy individuals test positive at 1:160 1, 2
- Recommended screening dilution for adults when balancing sensitivity, specificity, and cost 1
- High specificity (95% of normals excluded) but reduced sensitivity (89.3% for CTDs) 3, 2
Critical Pitfalls
Low-titer ANA results are NOT necessarily insignificant—the guidelines explicitly state that titers following the screening threshold have no bearing on diagnosis or disease activity 1. A positive result at 1:40 in a healthy person differs fundamentally from the same titer in someone with clinical symptoms of autoimmune disease.
The pattern of fluorescence matters as much as the titer itself, as patterns reflect specific autoantigen targets and guide reflex testing for disease-specific antibodies 1.